Macmillan Cancer Support
To add a bio or update investment portfolio, please click update information.
Investment Portfolio


Hypervision Surgical secures a £17m Series A led by Heal Capital to equip surgeons with next-gen tissue imaging
Hypervision Surgical develops imaging technology that provides real-time insights into tissue during surgery. Its platform enables surgeons to assess tissue physiology beyond what is visible to the human eye, supporting intraoperative decision-making.


Lucida Medical secures £8.7m in funding led by IW Capital to detect early prostate cancer in scans with AI
Lucida Medical develops software to help clinicians detect prostate cancer from MRI scans. It analyses scans to highlight suspicious areas and support faster and more consistent diagnostic decisions.


Infinitopes secures an £11m seed round led by Octopus Ventures and Amplify Bio to prevent recurrence of oesophageal cancer
Infinitopes develops off-the-shelf precision cancer vaccines designed to prevent recurrence, using AI-powered immunomics to target shared tumour features and advance new immunotherapies into clinical trials.


Perci Health secures £3m from UK venture funds and Macmillan Cancer Support to scale virtual cancer clinic
Perci Health runs a virtual cancer clinic that combines digital tools with multidisciplinary specialist care, supporting patients through treatment, recovery and survivorship while addressing gaps in long-term cancer care provision.


Oncology medical tech startup 52North secures £5m with landmark UK-US hospital VC deal
52North builds medical devices and digital tools that support cancer patients outside hospital, focusing on early detection and monitoring of treatment-related complications to improve urgent oncology care pathways.
- 3(12 months)
- Update Information
More venture news
- 10 Jun 2026

Capsa AICapsa AI lands £14m Series A led by TX Ventures and Pivot Investment Partners to build the AI operating system for private capital
Series AAI - 9 Jun 2026

NewOrbitNewOrbit raises £14m in a Series A led by Voyager Ventures to build the first commercial satellites for very low Earth orbit
Series ADeep Tech - 2 Jun 2026

IMU BiosciencesIMU Biosciences unlocks £40m Series A led by IQ Capital and Molten Ventures to decode the immune system with high-resolution blood analysis
Series ALife Sciences